Apex Part 1: Updated Assessment of Bezuclastinib (CGT9486), a Selective KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (Advsm)Daniel J. DeAngelo,Jason Gotlib,Vinod Pullarkat,Pankit Vachhani,Tsewang Tashi,Stephanie Lee,Gary J. Schiller,Anthony M. Hunter,Miguel Piris-Villaespesa,Helena Pomares, Bulai Livideanu Cridtina,Khalid Shoumariyeh,Jonathan Lambert,Tracy I. George, Jay Patel,Cristina Papayannidis,Tania Jain,Michael W. Deininger,Andreas Reiter,Gabriela S. Hobbs, Lei Sun, Deepak Nagendra,Jenna Zhang,Amanda Pilla, Kim Dishman, Marcus Carden,Deepti H. RadiaBlood(2024)引用 0|浏览1AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要